← Back
Data updated: Jun 28, 2026
UNIV ALAHAMA BIRM
Generics Pharmaceuticals
UNIV ALAHAMA BIRM is a generic drug manufacturer with 1 FDA-approved products.
2022
Since
1
Drugs
-
Trials
0
New Drugs (2yr)
UNIV ALAHAMA BIRM's Key Drugs
UNIV ALAHAMA BIRM's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
No active drugs
UNIV ALAHAMA BIRM's Recent FDA Approvals
New NDA/BLA approvals for UNIV ALAHAMA BIRM over the last two years — novel drugs only, excluding generics and label supplements.
No recent approvals
UNIV ALAHAMA BIRM's Therapeutic Areas
Disease areas where UNIV ALAHAMA BIRM has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.
No indication data
UNIV ALAHAMA BIRM Pipeline Snapshot
Active clinical trials for UNIV ALAHAMA BIRM across all therapeutic areas, from ClinicalTrials.gov.
No active pipeline data available
Pro Expected Approvals & Milestones
Loading detailed analysis...
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Active trial monitoring
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Unlock Full Intelligence
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 2022-11-03
- Latest
- 2022-11-03
- Applications
- 1